最新公告列表 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 《第三届董事会第十九次会议决议公告》 《2025年限制性股票激励计划预留权益授予的激励对象名单》 《广东东方昆仑(东莞)律师事务所关于惠州市锦好医疗科技股份有限公司2025年第四次临时股东 会法律意见书》 《2025年第四次临时股东会决议公告》 截至2026年1月7日收盘，锦好医疗（920925）报收于27.84元，较前一交易日下跌14.76%，最新总市值 为27.41亿元。该股当日开盘31.44元，最高31.44元，最低27.38元，成交额达5.17亿元，换手率为 32.59%。 近日，惠州市锦好医疗科技股份有限公司公布2025年限制性股票激励计划预留权益授予名单，共授予3 名激励对象200,000股限制性股票。其中，高级管理人员张亮获授100,000股，占比50.00%；袁金鹏获授 50,000股，占比25.00%；核心员工钟梅获授50,000股，占比25.00%。上述股份合计占公司总股本的 0.20%。 ...

Core Viewpoint - On January 7, 2026, Jinhao Medical (920925) was featured on the stock exchange's "Dragon and Tiger List" due to a significant trading volume, with a turnover rate of 32.59% and a transaction amount of 517 million yuan [1][2]. Trading Activity Summary - The total trading volume for Jinhao Medical on that day was 18.02 million shares, with a total transaction value of 517 million yuan [1]. - The top buying seat was from Dongfang Caifu Securities, which purchased approximately 6.98 million yuan worth of shares [2]. - The top selling seat was from Guotai Haitong Securities, which sold approximately 58.67 million yuan worth of shares [2]. Detailed Trading Data - The following are the top trading departments: - Dongfang Caifu Securities, Lhasa Tuanjie Road First Securities Office: Buy 6,975,733.27 yuan, Sell 5,376,321.64 yuan [2]. - Bank of China International Securities, Shenzhen Branch: Buy 6,745,707.59 yuan, Sell 34,084 yuan [2]. - Dongfang Caifu Securities, Lhasa East Ring Road Second Securities Office: Buy 6,466,188.67 yuan, Sell 2,651,309.67 yuan [2]. - Guotai Haitong Securities, Chongqing Liberation Monument Office: Buy 0 yuan, Sell 58,674,322.99 yuan [2].

Group 1 - The core point of the article is that JinHao Medical announced the approval of the proposal to reappoint the accounting firm during its fourth extraordinary general meeting of shareholders in 2025 [2] Group 2 - The announcement was made on January 6, indicating the company's ongoing governance and compliance with regulatory requirements [2] - The decision reflects the company's commitment to maintaining transparency and accountability in its financial reporting [2]

Core Viewpoint - JinHao Medical (920925) experienced a significant decline of 14.57% in its stock price, with a trading volume turnover rate of 32.55% and a total transaction value of 597 million yuan, indicating high volatility in the market [2] Trading Activity Summary - The stock was listed on the North Exchange due to its turnover rate reaching 32.55%, with a total net sell of 47.16 million yuan from brokerage seats [2] - The top five brokerage seats accounted for a total transaction value of 191 million yuan, with a buying amount of 71.88 million yuan and a selling amount of 119 million yuan, resulting in a net sell of 47.16 million yuan [2] - The largest buying brokerage was Dongfang Securities Co., Ltd. Shanghai Qingpu District Wuxie Bang Road Securities Business Department, with a buying amount of 25.89 million yuan, while the largest selling brokerage was CITIC Securities Co., Ltd. Beijing Branch, with a selling amount of 28.80 million yuan [2] Detailed Brokerage Activity - The top five buying brokerages and their respective amounts were: - 1st: Dongfang Securities, 25.89 million yuan - 2nd: Dongya Qianhai Securities, 16.18 million yuan - 3rd: Dongfang Caifu Securities, 9.22 million yuan - 4th: Dongfang Caifu Securities, 9.14 million yuan - 5th: Huatai Securities, 9.00 million yuan [2] - The top five selling brokerages and their respective amounts were: - 1st: CITIC Securities, 28.80 million yuan - 2nd: CITIC Jiantou Securities, 22.72 million yuan - 3rd: Dongfang Caifu Securities, 22.43 million yuan - 4th: GF Securities, 16.79 million yuan - 5th: Bohai Securities, 16.69 million yuan [2]

Core Viewpoint - On January 6, 2026, Jinhao Medical (920925) was featured on the trading leaderboard of the Beijing Stock Exchange due to a high turnover rate of 32.55%, with a trading volume of 17.9983 million shares and a transaction value of 597 million yuan [1][2]. Group 1 - Jinhao Medical's closing price on the trading day was 32.66 yuan [1]. - The top buying seat was from Dongfang Securities Co., Ltd., Shanghai Qianpu District, with a purchase amount of approximately 25.89 million yuan [1][2]. - The top selling seat was from CITIC Securities Co., Ltd., Beijing Branch, with a selling amount of approximately 28.80 million yuan [1][2]. Group 2 - The total transaction amount for Jinhao Medical on that day reached 597 million yuan [1]. - The trading volume was reported at 17.9983 million shares [1]. - The turnover rate of 32.55% indicates significant trading activity for the stock [1].

Group 1 - The core stock price of JinHao Medical (920925) closed at 38.23 yuan on January 5, 2026, with an increase of 20.03% and a turnover rate of 19.58%, resulting in a trading volume of 108,300 lots and a transaction amount of 394 million yuan [1] - On January 5, the net inflow of main funds was 84.54 million yuan, accounting for 21.44% of the total transaction amount, while retail investors had a net inflow of 1.80 million yuan, representing 0.46% of the total transaction amount [2][4] - JinHao Medical was listed among the top 5 stocks on the Dragon and Tiger List due to its closing price increase of 20% on January 5, marking its first appearance on the list in the past 5 trading days [3][4]

Group 1 - The stock of JinHao Medical (920925) increased by 20.03% today, with a turnover rate of 19.58% and a total transaction amount of 394 million yuan, showing a volatility of 29.18% [1] - The stock was listed on the exchange due to its daily price fluctuation reaching 20.03%, with a total net selling amount of 16.5892 million yuan from brokerage seats [2] - The top five brokerage seats accounted for a total transaction of 120 million yuan, with a buying amount of 51.5093 million yuan and a selling amount of 68.0984 million yuan, resulting in a net selling of 16.5892 million yuan [2] Group 2 - The largest buying brokerage was Huatai Securities Co., Ltd. Shenzhen Qianhai Securities, with a buying amount of 13.12 million yuan, while the largest selling brokerage was Debon Securities Co., Ltd. Shanghai Zhengli Road Securities, with a selling amount of 15.5407 million yuan [2] - Detailed trading information shows that the top five buying brokerages had no selling amounts, while the top five selling brokerages had significant selling amounts, indicating a strong selling pressure [2]

Group 1 - The core point of the article is that JinHao Medical (stock code: 920925) experienced a significant price increase of 20.03% on January 5, 2026, leading to its appearance on the stock market's "Dragon and Tiger List" [1][3] - The trading volume for JinHao Medical on that day reached 10.8265 million shares, with a total transaction value of 394 million yuan [1][2] - The top buying position was held by Huatai Securities Co., Ltd. with a purchase amount of approximately 13.12 million yuan, while the top selling position was held by Debon Securities Co., Ltd. with a selling amount of approximately 15.54 million yuan [1][2] Group 2 - The article provides detailed trading data, including the top five buying and selling brokerage firms, highlighting significant transactions from various securities companies [2] - Notably, the second-largest buying position was from China Galaxy Securities with approximately 11.51 million yuan, and the third from Dongfang Securities with about 10.48 million yuan [2] - On the selling side, the second-largest selling position was from Guosen Securities with approximately 15.24 million yuan, indicating a competitive trading environment [2]

Group 1 - The medical device sector experienced a significant increase of 5.5% on January 5, with JinHao Medical leading the gains [1] - The Shanghai Composite Index closed at 4023.42, up 1.38%, while the Shenzhen Component Index closed at 13828.63, up 2.24% [1] - Notable individual stock performances included JinHao Medical with a closing price of 38.23, up 20.03%, and BoTuo Bio with a closing price of 45.34, also up 20.01% [1] Group 2 - The medical device sector saw a net inflow of 1.678 billion yuan from institutional investors, while retail investors experienced a net outflow of 644 million yuan [2] - The top individual stock in terms of net inflow was AiPeng Medical, with a net inflow of 1.57 million yuan, representing 25.59% of its trading volume [3] - Conversely, major outflows were observed in stocks like MaiRui Medical, which had a net outflow of 91.39 million yuan from retail investors, accounting for 2.74% of its trading volume [3]

证券日报网讯 12月15日晚间，锦好医疗发布公告称，公司第三届董事会第十八次会议审议通过《关于 公司续聘会计师事务所的议案》等多项议案。 （文章来源：证券日报） ...